JPM vs PSTV · P/E 14, rev $57.35B vs P/E 0.2, rev $5.8M
JPMorgan Chase & Co (JPM) versus Plus Therapeutics Inc (PSTV) — a side-by-side from cached financials, not a winner call.
JPMorgan Chase & Co (JPM) is a banks - diversified company listed on US. It is led by Jamie Dimon.
Plus Therapeutics Inc (PSTV) is a biotechnology company listed on NASDAQ.
Latest reported JPM revenue for 2026-06-30 was $57.35B. Net income was $21.16B. Revenue was up 15.1% from 2026-03-31 to 2026-06-30. JPM currently screens at market cap $805.69B and trailing P/E 14.2.
Latest reported PSTV revenue for 2024-12-31 was $5.8M. Net income was -$13.0M. Revenue was up 18.5% from 2023-12-31 to 2024-12-31. PSTV currently screens at market cap $29.7M and trailing P/E 0.2.
JPM currently screens at market cap $805.69B and trailing P/E 14.2. PSTV currently screens at market cap $29.7M and trailing P/E 0.2.
Not investment advice. Open the JPM and PSTV stock pages for the full models.
Not investment advice.